Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy: PIK3CA activating mutations in invasive lobular breast carcinoma. Radiol Oncol [Internet]. 2023 Jun. 22 [cited 2026 Jul. 31];57(2):220-8. Available from: https://www.ojstest.computing.si/index.php/ro/article/view/4055